New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording
New Webinar - View recording

suPAR has excellent prognostic utility in predicting severe COVID-19 complications

Wed Apr 14 2021

Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Associate with Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study

Published in the International Journal of Infectious Diseases

A brand new study discloses that suPAR has excellent prognostic utility in predicting severe COVID-19 complications in hospitalized patients.

The ongoing pandemic exerts continuous pressure on hospitals. The current standard of care for triaging COVID-19 patients relies on routine clinical and laboratory assessment but offers limited prognostic information.

The study’s results demonstrate that COVID-19 patients with increased baseline suPAR levels are at a high risk of developing complications, which can significantly improve COVID-19 triage. It is essential to correctly identify patients that may be safely discharged home, those who need hospitalization, and those at risk of deterioration, potentially requiring ICU admission.

Highlights:

  • suPAR has been suggested as a good prognosis for severe complications of COVID-19.
  • COVID-19 patients with increased suPAR are at high risk of developing complications
  • Increasing suPAR by 1 ng/mL leads to 58% rise in the risk of getting complications.

suPAR has excellent prognostic utility in predicting severe COVID-19 complications

– Oulhaj et al, International Journal of Infectious Diseases, April 2021

Read the study here

+700

published suPAR studies in leading medical journals

The suPARnostic® brand consists of the following 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

Would you like to know more?

If you have any questions regarding our products or business, write to us here

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

Sign up for our newsletter

By signing up for our newsletter you will receive the latest news about our products.

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

suPARnostic® by ViroGates